Tue, March 13, 2012
Mon, March 12, 2012
Sat, March 10, 2012
Fri, March 9, 2012
Thu, March 8, 2012
Wed, March 7, 2012
Tue, March 6, 2012
[ Tue, Mar 06th 2012 ]: Market Wire
Verotoxin and E. coli 0157
Mon, March 5, 2012
[ Mon, Mar 05th 2012 ]: Market Wire
Sienna Gold Warrants Extended
[ Mon, Mar 05th 2012 ]: Market Wire
30 a.m. ET
Fri, March 2, 2012
Thu, March 1, 2012
Wed, February 29, 2012

China Pharma Holdings, Inc. to Report Fiscal Year 2011 Financial Results on March 15, 2012


  Copy link into your clipboard //health-fitness.news-articles.net/content/2012/ .. ear-2011-financial-results-on-march-15-2012.html
  Print publication without navigation Published in Health and Fitness on by Market Wire


China Pharma Holdings, Inc. to Report Fiscal Year 2011 Financial Results... -- HAIKOU CITY, China, March 6, 2012 /PRNewswire-Asia-FirstCall/ --

China Pharma Holdings, Inc. to Report Fiscal Year 2011 Financial Results on March 15, 2012

[ ]

HAIKOU CITY, China, March 6, 2012 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: [ CPHI ]), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it plans to release its fiscal year 2011 financial results before the market opens on Thursday, March 15, 2012.

The Company will hold a conference call at 8:30 am ET on March 15, 2012 to discuss fiscal year 2011 results.  Listeners may access the call by dialing 1-866-519-4004 or 65-672-393-81 for international callers, Conference ID # 59409919. A webcast will also be available through CPHI's website at [ http://www.chinapharmaholdings.com ].  A replay of the call will be accessible through March 22, 2012 by dialing 1-866-214-5335 or 61-282-355-000 for international callers, Conference ID # 59409919.

About China Pharma Holdings, Inc.

China Pharma Holdings, Inc. is a specialty pharmaceutical company with rapidly growing profit that develops, manufactures, and markets treatments for a wide range of high incidence and high mortality conditions in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective, high margin business model is driven by market demand and supported by eight scalable GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding distribution network across 30 provinces, municipalities and autonomous regions. The Company is registered in Delaware, USA. Hainan Helpson Medical & Biotechnology Co., Ltd. (Helpson), located in Haikou City, Hainan Province, China, is a wholly owned subsidiary of China Pharma Holdings, Inc. For more information about China Pharma Holdings, Inc., please visit [ http://www.chinapharmaholdings.com ].

cellpadding="0" cellspacing="0" id="convertedTable" style="BORDER-RIGHT: 1pt; BORDER-TOP: 1pt; BORDER-LEFT: 1pt; BORDER-BOTTOM: 1pt; BORDER-COLLAPSE: collapse">

Contact:

China Pharma Holdings, Inc.                                          

Phone: +86-898-6681-1730 (China)                                 

Email: [ hps@chinapharmaholdings.com ]       

SOURCE China Pharma Holdings, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.chinapharmaholdings.com ]


Publication Contributing Sources

Publication Sponsors
[ Last Sunday ] - Oceanside Rental Gear